Bright key facts / Experimental
A new lead against resistant bacteria.
Scientists identified abaucin, a compound active against Acinetobacter baumannii, with help from deep learning.
- AI’s role
- A model prioritized compounds for laboratory testing.
- Documented result
- Abaucin showed activity in experiments, including a mouse wound infection model.
- Important limitation
- Preclinical evidence. Human safety and efficacy are not established.